• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA clears surgical navigation system from Proprio

FDA clears surgical navigation system from Proprio

April 25, 2023 By Sean Whooley

Proprio Paradigm surgical visualization system
The Paradigm surgical visualization system. [Image courtesy of Proprio]
Proprio announced today that it received FDA 510(k) clearance for its Paradigm surgical navigation platform.

Seattle-based Proprio designed Paradigm to replace traditional surgical navigation technologies. Using an advanced approach, it avoids the pitfalls that pull attention away from the patient and disrupt workflows.

According to a news release, Paradigm is the first such system to use light field technology in spine surgery navigation. This process creates a real-time view of the anatomy and surgical scene, Proprio said. The system features an advanced sensor suite to capture high-definition, multi-modal intraoperative images. It then fuses that information with preoperative scans.

With the platform, surgeons can access helpful data, Proprio said. That includes intraoperative imaging and powerful visualization capabilities. Plus, it operates without any harmful radiation or impediment to their workflow. Proprio calls this data fusion capability “Volumetric Intelligence.”

Read here about how Proprio’s Paradigm system could improve orthopedic surgeries.

Other benefits include a reduction in radiation, an accelerated workflow, fast registration and continuous data capture. Proprio’s Paradigm can reduce workflow by up to 30 minutes per procedure and complete registration in seconds. It can collect approximately 250GB of data per hour, too.

“We are very enthusiastic about the potential for Paradigm to enable clinicians to revolutionize spine surgery,” said Gabriel Jones, CEO and co-founder of Proprio. “We’re reimagining how surgery is done, rather than reconfiguring legacy tools. This uniquely positions our system to effectively capture the valuable data needed to feed advanced computer vision and deep learning models to recognize, track and analyze complex anatomical structures.

“The potential of this technology in the hands of skilled clinicians has us all very optimistic about the future of surgical practice.”

Filed Under: 510(k), Digital Health, Food & Drug Administration (FDA), Health Technology, Imaging, Orthopedics, Regulatory/Compliance, Software / IT, Surgical Tagged With: Proprio

More recent news

  • Cambridge Heartwear inks £184M deal to supply NHS with portable ECG monitors
  • J&J, Smith+Nephew plans for ortho megamerger reportedly fall through
  • California and Massachusetts still reign as top US medtech headquarters locations
  • Teleflex wins Breakthrough Device designation for Freesolve resorbable scaffold
  • FDA clears Solventum’s combo wound care platform following Acera acquisition

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy